Albany, NY -- (SBWire) -- 12/15/2017 --According to a research report by Transparency Market Research (TMR), the global myasthenia gravis market is anticipated to be worth US$2,313.1 mn by the end of 2025 from a valuation of US$975.1 mn in 2016. During the forecast period of 2017 and 2025, the global myasthenia gravis market is projected to clock a CAGR of 10.1%.
The Global Myasthenia Gravis Market is segmented on the basis of Treatment and region.
The drug treatment segment is sub-segmented into cholinesterase inhibitors, monoclonal antibodies, and chronic Immunomodulators. The rapid immunotherapies segment is categorized into plasmapheresis and intravenous immunoglobulin. The cholinesterase inhibitors within drug treatment sub-segment blocks the breakdown of acetylcholine which acts as a neurotransmitter in both central and peripheral nervous system.
Read Report Overview @ https://www.transparencymarketresearch.com/myasthenia-gravis-market.html
The global myasthenia gravis market on the basis of geography has been segmented into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. Among them, North America is a key market for myasthenia gravis. According to statistics of Center for Disease Control & Prevention, the prevalence of myasthenia gravis is estimated to be from 14 to 20 per 100,000 population in the United States.
Europe follows North America in terms of revenue contribution to the global myasthenia gravis market. This is mainly because of a growing geriatric population and increasing prevalence of myasthenia gravis.
Asia Pacific, Latin America, and the Middle East and Africa are largely untapped market for myasthenia gravis. Asia Pacific is likely to display leading growth rate among other key regions for myasthenia gravis over the forecast period. Several governmental and non-governmental organizations in the region are involved in organizing awareness programs which is expected to propel the myasthenia gravis market in the region.
Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26105
Summary of Table of Content
1 Preface
2 Assumptions and Research Methodology
3 Executive Summary
4 Market Overview
5 Market Dynamics
6 Global Myasthenia Gravis Market Analysis, by Treatment
7 Myasthenia Gravis Market Analysis, by Region
8 North America Myasthenia Gravis Market Analysis
9 Europe Myasthenia Gravis Market Analysis
10 Asia Pacific Myasthenia Gravis Market Analysis
11 Latin America Myasthenia Gravis Market Analysis
12 Middle East & Africa Myasthenia Gravis Market Analysis
13 Competition Landscape
Request to Browse Full Table of Content, figure and Tables @ https://www.transparencymarketresearch.com/report-toc/26105
Global Myasthenia Gravis Market: Segmental Highlights and Table of Content (2017-2025)
Global Myasthenia Gravis Market: Research for Introduction of Novel Therapeutics to Play Key Role in Growth, finds TMR